Trial Profile
A Study to Evaluate the Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Apr 2017
Price :
$35
*
At a glance
- Drugs Japanese encephalitis vaccine (Primary) ; Varicella zoster virus vaccine live (Primary)
- Indications Chickenpox; Japanese encephalitis
- Focus Therapeutic Use
- Sponsors Changchun Keygen Biological Products
- 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Apr 2013 New trial record